treatment and prevention of vitamin d metabolite-mediated hypercalcemia/hypercalciuria consist of pharmacologic inhibition of the abnormal 1-hydroxylation reaction and limitation of substrates for the reaction .
C0014695
vitamin d
C0020437
hypercalcemia